Ernexa TherapeuticsERNA
13F holders, Q2 2026 (June 30)9holders
1famous investor
$6.65avg. 13F price*
At the end of Q2 2026, 9 institutions reported holding Ernexa Therapeutics Inc. (ERNA) in their 13F filings. The largest holders were Citadel Advisors ($100K), Vanguard Fiduciary Trust Co. ($55K) and Dauntless Investment Group, LLC ($40K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Ernexa Therapeutics Inc.
- CUSIP
- 114082407
- Latest filing quarter
- Q2 2026
Total Exit/New Position Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $236K |
| Exits | 0 | $0 |
Ownership 9 holders
| Citadel Advisors | 0.00% | New | 15,104 | $100K |
| Vanguard Fiduciary Trust Co. | 0.00% | New | 8,336 | $55K |
| Dauntless Investment Group, LLC | 0.07% | New | 6,000 | $40K |
| Vanguard Capital Management LLC | 0.00% | New | 5,684 | $38K |
| Tradewinds Capital Management, LLC | 0.00% | New | 361 | $2K |
| BlackRock, Inc. | 0.00% | New | 33 | $219 |
| Assetmark, Inc. | 0.00% | New | 5 | $33 |
| BNP Paribas Financial Markets | 0.00% | New | 1 | $7 |
| SBI Securities Co., Ltd. | 0.00% | New | 1 | $7 |
"% of holder's portfolio" is ERNA's weight in each manager's 13F, not the share of Ernexa Therapeutics Inc. the manager owns.